Home » Topics » Conferences

Conferences
RSS

COL-1492 can be used several times daily without safety concerns

July 13, 1998

PRO-2000 prevents infection by STD pathogens other than HIV

July 13, 1998

Impaired glucose tolerance and diabetes mellitus in AIDS patients treated with protease inhibitors

July 13, 1998

Phase I/II trial data released for P&U protease inhibitor

July 13, 1998

AIDS vaccine combination is safe and immunogenic in seronegative volunteers

July 10, 1998

French group develops new inhibitors of HIV-1 protease dimerization

July 10, 1998

AMD-3100: a potent chemokine CXCR4 antagonist enters clinical testing

July 10, 1998

Anti-HIV peptide T-22 acts as a CXCR4 receptor antagonist

July 10, 1998

Enzo discovery paves the way for antisense therapy of AIDS

July 10, 1998

IL-4 fusion toxin shows potent antitumor activity in murine model of KS

July 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...